Hims & Hers and Noom Launch Compounded Peptide Brands, Bringing Unapproved Wellness Treatments Into Mainstream Telehealth Apps
Hims & Hers and Noom launched telehealth peptide brands offering compounded products that are not FDA-approved for marketed wellness uses, raising questions about evidence, safety and regulation.
Medical Daily ·